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After ingestion of a standardized dose of ethanol, alcohol concentrations were assessed, over
3.5 hours from blood (six readings) and breath (10 readings) in a sample of 412 MZandDZ twins
who took part in an Alcohol Challenge Twin Study (ACTS). Nearly all participants were
subsequently genotyped on two polymorphic SNPs in the ADH1B and ADH1C loci known to
affect in vitroADH activity. In the DZ pairs, 14 microsatellite markers covering a 20.5 cM region
on chromosome 4 that includes the ADH gene family were assessed, Variation in the timed series
of autocorrelated blood and breath alcohol readings was studied using a bivariate simplex design.
The contribution of a quantitative trait locus (QTL) or QTL’s linked to the ADH region was
estimated via amixture of likelihoodsweighted by identity-by-descent probabilities. The effects of
allelic substitution at theADH1B andADH1C loci were estimated in the means part of the model
simultaneously with the effects sex and age. There was a major contribution to variance in alcohol
metabolism due to a QTL which accounted for about 64% of the additive genetic covariation
common to both blood and breath alcohol readings at the ﬁrst time point. No effects of the
ADH1B*47His or ADH1C*349Ile alleles on in vivo metabolism were observed, although these
have been shown to have major effects in vitro. This implies that there is a major determinant of
variation for in vivo alcohol metabolism in the ADH region that is not accounted for by these
polymorphisms. Earlier analyses of these data suggested that alcohol metabolism is related to
drinking behavior and imply that this QTL may be protective against alcohol dependence.
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INTRODUCTION
Alcohol metabolism shows considerable variation
between individuals and this variation may have
consequences for individual differences in duration of
intoxication, alcohol intake, susceptibility to alcohol
dependence and other alcohol-related traits and dis-
orders. Because the initial and rate-limiting step in
alcohol metabolism is its conversion to acetaldehyde
by alcohol dehydrogenase (ADH), the alcohol dehy-
drogenase genes are prime candidates for the study of
genetic variation in circulating alcohol concentrations
after drinking.
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The ADH genes consist of a family of seven genes
at 4q22-4q23 (Osier, et al., 2002; Tsukahara and
Yoshida, 1989). One group of ADH genes, the Class I
ADH genes, ADH1A, ADH1B and ADH1C, form a
tandem, recently diverged and linked gene cluster
(Yasunami, et al., 1990). The transcribed products of
the Class I genes interact to form the dimeric holo-
enzyme by way of subunit combination (Smith et al.,
1971, 1973). No polymorphisms that aﬀect enzyme
activity have been described for the ADH1A gene, but
the effects of diallelic amino acid substitutions within
each of the ADH1B and ADH1C genes upon in vitro
enzyme kinetics are well documented (Bosron et al.,
1983; Edenberg and Bosron, 1997). Their kinetic
properties led to an hypothesis for an etiological role
in the development of problems associated with
drinking (Chen et al., 1999; Higuchi, et al., 1995;
Muramatsu, et al., 1995; Osier et al., 1999; Shen
et al., 1997; Whitﬁeld et al., 1997, 1998), by way of
their role in the metabolism of ingested alcohol.
Slower rates of alcohol metabolism enable the brain to
experience the eﬀects of alcohol for a longer time,
which may lead to dependence. Conversely, when
ethanol is metabolized quickly the disagreeable side
eﬀects of the ﬁrst metabolite, acetaldehyde, can be-
come apparent. The most compelling evidence for this
eﬀect involves the ADH1B locus in populations of
East Asian descent (Thomasson et al., 1991), where
the gene frequency of the ADH1B*2 allele (high in
vitro enzyme activity), reaches a frequency of circa
60%. This is not the case in Caucasians where the
ADH1B*2 allele has a population frequency of about
10%. Protection through avoidance of alcohol is
probably provided by the deterrent effects of accu-
mulated acetaldehyde. Such an effect is particularly
noticeable in those who, in addition to carrying the
ADH1B*2 allele, also carry the inactive acetalde-
hyde dehydrogenase (ALDH) allele ALDH2*2 (see
references in Chen et al., 1999; Osier et al., 1999), but
the eﬀects of ALDH2 deﬁciency and of the ADH1B*2
allele are independently signiﬁcant. There is also evi-
dence for an association of ADH1B with alcohol use
and dependence in Caucasians (Borras, et al., 2000;
Whitﬁeld et al., 1998).
The most plausible biochemical and physiologi-
cal explanation of these population based associa-
tions was thought to be found in the considerable
differences in the in vitro, Vmax, (the maximum rate of
ethanol oxidation when all ADH enzyme is com-
plexed with ethanol) of proteins encoded by the
ADH1B and ADH1C loci. Since the combined dif-
ference in the in vitro Vmax of the allozymes produced
by the two most extreme homozygotes at the ADH1B
and ADH1C loci is about 40-fold (Edenberg and
Bosron, 1997), an evaluation of the contribution of
these genes to in vivo alcohol metabolism variation is
of particular interest.
We evaluated the contributions of ADH1B and
ADH1C to in vivo metabolism using a joint asso-
ciation -- linkage approach. The simultaneous
analysis of association and linkage makes it possible
to identify other variants in addition to ADH1B
and ADH1C in the linked ADH gene cluster which
may inﬂuence alcohol metabolism. These variants
may include sequences concerned with transcription
and regulation which can be distant from their
target gene or gene family member (Blackwood and
Kadonaga, 1998; Engel, 1993; Orkin, 1990). Fur-
thermore, whilst ingested alcohol may not be the
ancestral substrate for all ADH genes, apart from
ADH5, they all may act on ethanol at high con-
centration (Beisswenger, et al., 1985; Edenberg,
2000), and with the further exception of ADH6 and
ADH7, are expressed in the human liver and are
major contributors to ethanol detoxiﬁcation
(Zgombic-Knight, et al., 1995). Although allelic
polymorphisms at the ADH1B and ADH1C loci
undoubtedly cause variation in the
in vitro kinetic properties, their contributions to the
overall genetic variance in alcohol metabolism,
in vivo, have yet to be assessed in a family design.
Interestingly the ADH1B*2 allele accounted for
only a small proportion (8.5%) of the total pheno-
typic variance of in vivo metabolism in a Jewish
population in which it reaches a frequency of 21%
(Neumark et al., 2004). In this same study there
was no evidence for a contribution from the
ADH1C locus.
A study of in vivo alcohol metabolism in Aus-
tralian twins and known as the Alcohol Challenge
Twin Study (ACTS), was carried out the over the
period, 1979--1981 (Martin et al., 1985). It has pro-
vided a unique resource as a set of time-related pro-
ﬁles of in vivo alcohol metabolism in young adult MZ
and DZ twins. Heritabilities of the peak blood alco-
hol level and rate of alcohol elimination were found
to be high (0.62±0.06 and 0.50±0.11 respectively) in
this sample.
In this paper we use multivariate structural
equation modeling (MSEM) of the blood and breath
readings of alcohol concentrations to model the effect
of a potential QTL (Boomsma and Dolan, 1998,
2000; Eaves et al., 1996; Martin et al., 1997). MSEM
was used to analyze the variation in time-dependent
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trajectories of alcohol level as a function of IBD
status in DZ twin pairs. The model implementation
was done in the program Mx (Neale, 1997), which
allows the simultaneous modeling of covariance and
means structures by the method of full information
maximum likelihood. The model for the means allows
the contribution of biologically important covariates
such as age and sex, as well as the eﬀects of measured
genotypes at the ADH1B and ADH1C loci to be
estimated. The inclusion of these covariates increases
the chance of satisfying the assumption of multivar-
iate normality of residuals implicit in the method,
which is especially important for genes likely to be of
large effect. It also provides a way of estimating the
contribution of polymorphisms at the ADH1B and
ADH1C loci to the QTL variance arising from the
ADH region as a whole.
Several theoretical studies have shown that a
multivariate analysis of correlated traits can result
in an increase in power to detect a QTL as com-
pared to individual univariate measures (Boomsma
and Dolan, 1998; Martin et al., 1997; Schmitz
et al., 1998). A simplex model (Boomsma and
Molenaar, 1987; Eaves et al., 1986) was used to
specify the covariance structure for timed reading
of alcohol concentration. This quasi-Markovian
model is more suited to the analysis of the time-
dependent auto-correlated data, than is univariate
analysis as it models the eﬀects of time. It is also
unconstrained by any particular kinetic model,
which is reasonable given the complexity of alcohol
metabolism, transport and exchange within the
body.
Two related hypotheses of the genetic causes of
in vivo alcohol metabolism are tested by reduced
versions of the model: (1) there is a QTL within the
ADH region that accounts for a signiﬁcant fraction
of the genetic variance associated with alcohol
metabolism in vivo; and (2) alleles at the ADH1B and
ADH1C loci are major contributors to this QTL, as
would be predicted from differences in their in vitro
Vmax.
MATERIALS AND METHODS
The Subjects and the Measurement of Alcohol
Metabolism
The 206 twin pairs who were participants in the
ACTS 1979--81, (Martin et al., 1985) were of Cau-
casian (mainly Northern European) ancestry. They
comprise 88 MZ (45 female and 43 male) twin pairs
and 118 DZ (42 female, 37 male and 39 opposite sex)
twin pairs. The age range of our subjects was quite
narrow (18--34) with 70% of subjects < age 25.
Measures of blood and breath alcohol levels (ex-
pressed as mg 100 ml)1) were recorded for twins fol-
lowing ingestion over 20 minutes of a weight-related
dose of ethanol (0.75 g kg)1) (Martin et al., 1985). The
measuresofbreathalcoholweremadeequivalenttothose
of blood alcohol by multiplying by the blood/breath
factor of 2100:1 (Whitﬁeld andMartin, 1994) and both
measures followed a Gaussian distribution. The mea-
surementapparatuswassometimesunreliableandboth
this and a revision of the protocol during this study
(WhitﬁeldandMartin, 1994) led to somemissingvalues
(Table I),particularly forbreathalcohol readings.
BloodsampleswerenotretainedaftertheACTSwas
completed. By 1990 it was apparent that genotyping of
individual subjects from whom data on blood alcohol
levels after alcohol challenge was already available
would allow testing of genotype--phenotype associa-
tions. Blood was collected from 372 of the original 412
subjects and typed for the ADH1B*47His and AD-
H1C*349Ile polymorphisms (Whitﬁeld et al., 1998).
DNA from these subjectswas used to obtain genotypes
for a set of 14 microsatellite markers that spanned the
ADHgeneregion.
Genetic Markers
Of the 14 microsatellite markers, three -- D4S231
and D4S2634 (centromeric) and EGF (telomeric)-ﬂanked
the cytogenetic region 4q22-4q25 that contains the ADH
gene family. The remaining 11 -- D4S2380, D4S1628,
Table I. Number of Twin Subjects for Whom Blood and Breath Alcohol Levels were Recorded in Relation to Zygosity
Time after ingestion (minute) Zygosity 40 56 68 83 100 123 143 160 182 213
Blood alcohol MZ -- 165 172 164 -- 176 102 -- 171 --
DZ -- 223 235 223 -- 235 167 -- 232 --
Breath alcohol MZ 168 161 168 158 168 167 94 168 168 168
DZ 226 221 232 222 232 231 163 232 231 232
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D4S1647, D4S2407, D4S1591, D4S1572, D4S1570,
D4S2623, D4S3256, and ADH1B (formerly, ADH2
(Duester et al., 1999)) and ADH1C (formerly, ADH3)
were tightly enclosed within the ADH gene family.
Polymorphism at the ADH1B locus is identiﬁed by the
alleles ADH1B*47His (formerly ADH1B*2) and AD-
H1B*47Arg (formerly ADH1B*1). Polymorphism at
ADH1C is identiﬁed as ADH1C*349Ile, (formerly
ADH1C*1) and ADH1C*349Val (formerly ADH1C*2).
Both loci were identiﬁed by PCR/RFLP methods
(Whitﬁeld et al., 1998). For brevity we have referred to
the alleles at these polymorphic loci by the simpler
notation ADH1B*1 or ADH1C*1 etc. A total of 105 DZ
and 78 MZ twin pairs were so genotyped at the ADH1B
and ADH1C (respectively ADH1B*Arg47His and AD-
H1C*Ile349Val) loci.
The locations and map-order of the markers
and organization of the ADH gene cluster on the
Fig. 1. Recombination map locations of genetic markers and location of the ADH gene family. The overall map is presented in physical order
and the direction of transcription of the ADH1 gene cluster is given.
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physical map (Fig. 1) was obtained from the UCSC
Genome Browser website; (Karolchik et al., 2003).
The DeCODE recombination map (Kong et al., 2002)
was accessed with ‘Cartographer’ software (National
Public Health Institute Helsinki, Finland website) and
provided a genetic map position for all markers except
D4S231, ADH1B, ADH1C and EGF. Nucleotide map
positions of all markers were obtained from the
UCSC Genome Browser web site with the ‘BLAT
Search’ option. Primer assay sequences for the AD-
H1B*Arg47His and ADH1C*Ile349Val loci were
identiﬁed from within snp_view tables located within
the NCBI website, and locations cited within Osier
et al. (1999). The polymorphic site D4S231 was lo-
cated indirectly by taking the average location in Mb
of the respective and proximal and distal WI-18650
and B337WH9 markers within the UCSC Genome
Browser. The tetranucleotide microsatellite marker of
EGF is located within intron 10 (Murray et al., 1992).
A sex-averaged linear calibration of
1 MB=0.775046 cM for markers located on the De-
code map enabled unknown genetic distances to be
relationally placed on the recombination map.
IBD status was estimated for DZ twin pairs
using the above map. DNA was also obtained from
one or more parents for 63 of the 105 DZ twin pairs
and/or from one or more non-twin siblings of 55 of
the DZ pairs. These additional family members con-
tributed to checks on mistyping and to the estimates
of IBD status. Spurious double recombinants likely
to be the result of mistyping were identiﬁed by
detailed scanning of the IBD probabilities over the
25--30 cM interval.
The probabilities of IBD sharing status of 0, 1 or
2 alleles (p0, p1, p2) were calculated over the ADH
region for DZ pairs using the multipoint method of
Kruglyak and Lander (1995) implemented in
MAPMAKERSIBS2.1. For convenience we used
IBD probabilities estimated at a point intermediate in
position between ADH1B and ADH1C although the
calculated IBD probabilities were very well polarized
and consistent across the genotyped region. Haplo-
type conﬁgurations for ADH1B and ADH1C were
determined using SNPHAP (SNPHAP website). A
posterior probability of 0.85 was used to screen
unresolved haplotypes.
Structural Equation Modeling and Approach to QTL
Detection
Maximum likelihood methods were used to
estimate the contribution of genes and environment
to the time course of alcohol metabolism. They were
implemented with the structural equation modeling
package Mx (Neale, 1997) version 1.54 using the raw
data input option. The option enables missing data
points to be accommodated within the analysis fol-
lowing the procedure of Lange et al. (1976). All
analyses were carried out as mg. ethanol.100 ml.)1,
divided by 10 to facilitate numerical optimization in
Mx.
The approach to QTL detection involved the
parameterization of the expected twin covariance
matrices conditional upon the pairs sharing k alleles
IBD. The method maximizes the log-likelihood of the
observations and the marker data at particular loca-
tions across the genome. Following Eaves et al.
(1996) and Neale (2000), we deﬁne the log-likelihood
(ln L1) of a sibling pair, sharing k alleles IBD
(assuming that the distribution of the phenotypes, on
k follows a multivariate normal distribution), as:
ln LðXi; kÞ ¼ lnjRkjn  0:5ðxi  lÞ0R1k ðxi  lÞ
where Rk is the (2n · 2n) expected covariance matrix
for n variables measured on the ith sibling pair and | |
is the determinant of Rk. The means of the pheno-
types are given by the column vector l. The diﬀer-
ence between this log-likelihood (or ln L1) and the
log-likelihood, ln L0 in which a selected subset of j
parameters are ﬁxed at hypothesized parameter val-
ues, provides the basis of the log-likelihood ratio test
statistic, T=2(ln L1 ) ln L0), which is asymptotically
distributed as a v2 value for j degrees of freedom. In
the present model, hypothesis testing falls into two
categories, one concerned with the parameters mod-
eled in the expected sib pair covariance matrix and a
second for the tests of hypotheses of the predicted
means vector for the ith sib pair.
Previous analyses (Martin et al., 1985) and pre-
liminary multivariate analyses did not support the
inclusion of shared family environment eﬀects in the
expected covariance model which was parameterized
by the three covariance matrices: the residual or
background genetic matrix A, within family envi-
ronment matrix E, and the matrix containing the
contributions of the linked QTL effects, Q.
Aþ EþQ 0:5Aþ pkQ
0:5Aþ pkQ Aþ EþQ
 
;
where pk, is the expected proportion of a random
sample of sib pairs sib pairs taken from a panmictic
population, that share k alleles IBD where k = (0, 1,
or 2).
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The weighted likelihood method (Dolan et al.,
1999; Fulker and Cherny, 1996; Neale, 2000) was used
to estimate QTL eﬀects. An expected covariance ma-
trix a DZ pair is deﬁned for each of the three IBD
states 0, 1 and 2 in which pk=k/2. The probabilities
for the ith DZ pair for the three IBD states of 0, 1 and
2 were used as the mixing proportions of the three
expected covariance matrices. The expected panmictic
probabilities of 0.25, 0.5 and 0.25, corresponding to
the respective IBD states 0, 1 and 2, were used (Eaves
et al., 1996) for those 7 DZ twin pairs for whom
information on IBD status was unavailable. The
assignment of the expected panmictic IBD probabili-
ties to ungenotyped sibling pairs has been criticized
(Schork andGreenwood, 2004) because it leads to bias
towards the null hypothesis with some methods of
linkage detection (Cordell, 2004). As shown by Dolan
et al., (1999), when calculated IBD’s are available
only for phenotypes at the extremes of the phenotypic
distribution the pi-hat method of QTL estimation
leads to a marked upward bias in the test statistic; this
is not the case when the weighted likelihood model is
used. As noted by Cordell (2004), the methods we
have adopted in this study for the treatment of missing
IBD information should not result in bias. Although
no information about linkage is obtained from MZ
twins, they were included in the analysis as a separate
group since they are informative in the estimation of
the eﬀects of the measured genotypes at the ADH1B
and ADH1C loci and in the estimation of the total
heritability of the traits. Cholesky decomposition was
used to saturate the covariance structure due to spe-
ciﬁc environmental effects, since these were of sec-
ondary interest and this ensures conservative tests of
the genetic components of covariance.
Bivariate Time-series Modeling of Blood and Breath
Alcohol Levels
The simplex model provides a natural descrip-
tion of covariation from repeated measurements of
the same subjects across time (Boomsma and Mole-
naar, 1987; Eaves, et al., 1986) such as our series of
timed measurements of blood and breath alcohol
levels that describe the eﬀects of in vivo alcohol
metabolism following the prescribed dose of ethanol.
The bivariate simplex process (Boomsma and Mole-
naar, 1987) was used to model the QTL (Q) and the
residual genetic (A) effects common to both blood
and breath measures as well as QTL and residual
genetic effects speciﬁc to either blood or breath
measurements. The bivariate simplex model (Fig. 3)
was used to estimate the time dependent innovations
and the transmission parameters of the common and
the speciﬁc time series. Details of how the model was
speciﬁed and of the procedure used to estimate the
latent residual genetic (or QTL) parameters are given
in the Appendix A.
The Means Model
The predicted means vector was deﬁned for each
time point as a grand mean, m, and a matrix of
regression weights bk, post multiplied by a vector of
kij covariate values, for the jth sibling of the ith
sibpair and kth covariate. Maximum likelihood esti-
mates (MLE) of means effects, sex and age and the
effects of haplotypes at the ADH1B and ADH1C loci
are obtained jointly with the QTL and residual
genetic covariances. The method due to Fulker et al.
(1999) provides a joint test the contribution of the
measured genotypes to linkage. The amino acid
substitutions that identify the ADH1B* Arg47His
and ADH1C*Ile349Val loci lead to marked changes
of in vitro Vmax so making them good candidates for
in vivo ADH metabolism. If the effects of the mea-
sured genotypes are singularly causal to the observed
linkage they will absorb a signiﬁcant proportion of
the QTL variation.
RESULTS
The Effects of Sex and Age
Males had lower blood and breath alcohol con-
centrations (BAC, Fig. 2) than females. For breath
readings this eﬀect was strongly associated with time
and was greatest towards the end of the time series
(v29 ¼ 34.12; <0.0001). A similar trend was apparent
but not statistically signiﬁcant for blood readings
(v25 ¼ 4.52; p=0.48) which, compared to the readings
for breath alcohol level, covered a more restricted
time span that centered at the height of the parabolic
relation for the time course of alcohol metabolism.
The effect of sex measured as a male deviation
amounted to an average of )9.13 mg 100 ml)1 for
breath and )8.82 mg 100 ml)1 for blood alcohol
concentration. There was no age · time interaction
eﬀect on either blood (v25 ¼ 4.57; p=0.47) or breath
(v29 ¼ 14.79; p=0.10) alcohol concentration level.
There was a clear linear regression of alcohol level
upon age, (as a time independent effect), of
0.04 mg.100 ml)1 yr)1 for both blood and breath
measurements (v21 ¼ 9.04; p<0.001 and v21 ¼ 12.66;
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p<0.001 respectively. Both sex and age were retained
in the means model for all subsequent modeling of
covariance structure.
Genetic Modeling
QTL Detection
The contribution of a putative QTL to the
expected sib pair covariance matrices involved the
speciﬁcation of an expected covariance matrix Q. The
effects of Q were modeled through a bivariate (i.e.
blood and breath measurements) simplex model that
was identical to that used for the residual genetic
covariance matrix A, except for the genetic correla-
tions between genotypes of twins. These correlations
depend on IBD status for Q and were ﬁxed at 0.5 for
A for DZ twins. Identiﬁcation of the bivariate sim-
plex models for A and Q was achieved by starting the
simplex processes that are speciﬁc to blood or speciﬁc
to breath at the second time of measurement
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Fig. 2. Time course of Blood (——) and Breath alcohol (- - - -) concentration (mg ml)1) after for Female (n) and Male (}) participants in the
Alcohol Twin Challenge Study.
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(Boomsma, et al., 1989). The structure of the model
describing the QTL structure was simpliﬁed from the
full bivariate simplex structure, whilst the model for
the residual genetic covariance was retained to ensure
conservative tests of QTL eﬀects. A set of nested sub
models of the full weighted likelihood model for QTL
eﬀects provided tests of the contribution of the QTL
to both the speciﬁc (blood or breath measurements)
and to the common simplex processes (Table II).
Simpliﬁcation of the fully speciﬁed bivariate
simplex QTL model proceeded by testing for the
contribution of the QTL processes speciﬁc to blood,
and that speciﬁc to breath. Both speciﬁc processes
could be dropped from the simplex structural model
that deﬁned the QTL (Table II, Model 2); the genetic
components of the variation speciﬁc to either blood
or breath levels are unrelated to IBD status. In
striking contrast, dropping the entire part of the
simplex model concerned with the QTL for the
common covariance (QJ) between blood and breath
measures from the model (Table II, Model 3) led to
a drastic worsening of model ﬁt (v219 ¼ 65.99;
p<10)8).
The ﬁrst innovation variance of the QTL process
is unique in our simpliﬁed model for covariance
associated with the QTL (Fig. 4) and inspection of
the relative magnitude of the. ﬁrst innovation for QJ
(Fig. 4) indicated that most genetic variance due to
the QTL does indeed arise at the beginning of the
time series. On dropping the ﬁrst QTL innovation in
the time series (Table II, Model 4), the change of ﬁt
of was considerable (v21 ¼ 34.41; p<10)8), showing
Fig. 3. Speciﬁcation of the bivariate simplex model for the time course of the observed measurements h. There are 10 time points for breath
and 6 time points for the blood alcohol concentrations. The joint latent genetic (A) (or QTL (Q)) process as estimated from the covariance
between blood and breath alcohol readings is indicated bys as with labels J1-10. The symbols, RS 2--8 or LS2,3,4,6,7 and 9, relate to those simplex
processes that are respectively speciﬁc to breath or blood measures at the indicated times. Innovations of variance (nrj1-- rj10) are shown for the
common genetic (or QTL) covariance, the covariance speciﬁc to blood and that speciﬁc breath, are shown as . They are depicted in the
identiﬁed model in relation to the latent variables. Transmission paths (b) for the speciﬁc process for blood, breath and those for the process
common to both breath and blood are related to the timing of readings by the respective suﬃxes, (bls, brs, and bj) . The transmission paths for
blood readings take into account missing time points. Latent or k variables are speciﬁed for the common pathway to enable the relative
contributions of blood and breath readings in the time series to be compared. The model shown in this diagram is ﬁtted for both A and Q. In
addition a Cholesky decomposition of E is ﬁtted.
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that the QTL for alcohol metabolism is indeed
manifested soon after drinking. The model for QJ was
found to further simplify from that deﬁned by Model
2. A reduced form of QTL structure (Fig. 4) was
obtained by equating the nine transmission paths for
QJ (v29 ¼ 13.38; p=0.10), where the relative size of the
innovation of variance at time 1 can be seen relative
to the contributions at subsequent time points. In-
deed dropping the nine small innovations of covari-
ance subsequent to the major innovation seen at time
1 did not result in a reduction in model ﬁt
(v29 ¼ 15.044; p=0.09). The reduced model for QJ led
to a change of ﬁt of (v22 ¼ 37.57; p<10)8), which is
very similar to Model 4 in (Table II). The percentage
of total genetic variance in alcohol metabolism
accounted for by the QTL speciﬁed by the innovation
at the ﬁrst time point was 64% with 95% CI’s of
56.7% and 66.5% (estimated by the method of Neale
and Miller (1997)).
Effects of Haplotypes at the ADH1B and ADH1C
Loci
The effects of haplotypes (Table III) at the biallelic
ADH1B and ADH1C loci were estimated in the
means part of the expected likelihood equation. Three
of the four possible haplotypes namely ADH1C*1--
ADH1B*1 (52.8%), ADH1C*2--ADH1B*1 (43.1%),
and ADH1C*1 -- ADH1B*2 (4.1%) were identiﬁed
(SNPHAP website) in this sibpair sample. The popula-
tion frequencies of the ADH1C*1 and ADH1B*2 alleles
in the ACTS sample were 0.569 and 0.037 respectively.
Table II. Simpliﬁcation of the Bivariate Simplex Model (Fig. 3) for QTL Eﬀects
Model Comparisona
Residual
genetic covarianceb QTL covariancec Goodness of ﬁt
AJ ARS ALS QJ QRS QLS )2LL df v
2 df p
1 1 Y Y Y Y Y Y 12963.18 5812
2 1 Y Y Y Y N N 12980.68 5836 17.492 24 0.83
3 2 Y Y Y N N N 13046.67 5855 65.995 19 <10)6
4 2 Y Y Y Yd N N 13015.09 5837 34.412 1 <10)8
aThe baseline model for tests of the change in log likelihood and hence model ﬁt.
bAJ, ARS and ALS are those partitions of the model for the latent residual genetic covariance that respectively describe the joint covariance
breath and blood measures that which is speciﬁc to breath, and that process speciﬁc to blood.
cQJ, QRS and QLS are the corresponding eﬀects described above for the contribution of the linked QTL.
R3 R4R2 R5R1 R6
J1 J2 J3 J4 J5 J6
λrj1 =1 λrj2=1 λrj3=1 λrj4=1 λrj5=1 λrj6=1
R7 R8 R9 R10
J8 J9 J10
λrj7=1 λrj8=1 λrj9=1
J7
λrj10=1
L3 L4L2 L6 L7 L9
1.391 1.544 1.329 0.430 0.656 1.155
1.19 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.06 0.01
0.6
9
0.6
9
0.6
9
0.6
9
0.6
9
0.6
9
0.6
9
0.6
9
0.6
9
Fig. 4. Model for QTL covariance showing the contributions of blood and breath measures to the QTL for alcohol metabolism following
the nomenclature given in Fig. 3. The joint latent QTL process (QJ1 QJ10) between blood and breath alcohol readings is indicated here by J1
to J10.
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Phase was only a potential problem for a small part of
the sample; i.e. for those cases (15) for which both loci
are heterozygous and all of these were at p>0.85.
The standardized coefﬁcient of linkage disequi-
librium D¢ value (or D/Dmax, Lewontin, 1964, 1988)
for this sample was )0.76. There was no evidence of
heterogeneity of haplotype eﬀects in relation to times
at which the blood or breath alcohol readings were
taken. Similarly the eﬀects of the haplotypes, respec-
tively encoded (in 5¢-3¢ orientation) as 1-1, 2-1 and 1-2,
upon blood or breath alcohol readings were homoge-
neous when constrained across time. The eﬀect size
(measured as deviation from the mean) of the 1-1
haplotype was 0.45 mg 100 ml)1 (v21 ¼0.26; p=0.61),
for the 2-1 haplotype it was 0.53 mg 100 ml)1
(v21 ¼ 2.7; p=0.10, whilst that for the 1-2 haplotype
was 3.26 mg 100 ml)1 (v21 ¼ 3.84; p=0.05). The con-
tribution of the 1-2 haplotype, although small is
associated with the effects of the ADH1C*1 and
ADH1B*2 alleles and represents that combination of
alleles with the highest in vitro activities at these loci.
The association due to haplotypes provides the most
informative test of the hypothesis that our QTL is due
to polymorphism at the ADH1C and ADH1B loci and
was marginally more sensitive than one based upon
allelic association alone (v21 ¼ 2.32; p=0.12 for the
ADH1B locus and v21 ¼ 2.35; p=0.13 for the ADH1C
locus). However, although the effect of the 1-2 hap-
lotype is signiﬁcantly different from zero (p=0.05), its
effect size is small and its contribution to the genetic
variance attributable to the ﬁrst QTL innovation of
covariance common to both breath and blood mea-
sures was only 0.9%. Given the low frequency of
ADH1B*2, the contribution of this locus to the genetic
variance can be expected to be small in this Caucasian
population and account for a negligible fraction of
the genetic variance due to the QTL for alcohol
metabolism.
DISCUSSION
Phenotypic assessment of ethanol metabolism
was done in 206 pairs of twins by measuring blood
and BAC over a three hour time course following
ingestion of a weight related dose of ethanol. The
105 DZ twins for whom we had DNA were typed for
14 markers in the ADH region of chromosome 4. Sib
pair linkage analysis was used to see if we could
detect a linked QTL that accounted for a signiﬁcant
proportion of the variance in alcohol metabolism. Sib
pair linkage has notoriously low power (Risch and
Zhang, 1995). We began by performing linkage
analysis of the 16 individual blood and breath QTL
readings and in no case found a drop chisquare of >4
(i.e. LOD <1) at the ADH region. The point esti-
mates of percentage variance attributable to a QTL
and 95% CI’s (in brackets) for the six successive
measurements of blood alcohol concentrations were 0
(0--0.411), 0.197 (0--0.625) , 0 (0--0.608), 0.121 (0--
0.532), 0.46 (0--0.778) and 0.502 (0--0.719) and simi-
larly for the 10 breath alcohol times they were 0
(0--0.443), 0 (0--0.276), 0 (0--0.338), 0 (0--0.462), 0 (0--
0.211), 0 (0--0.265), 0 (0--0.366), 0.154 (0--0.549), 0
(0--0.369) and 0.173 (0--0.538). Whilst most estimates
of the QTL are poor, the upper 95% CI’s are often
greater that 50% of the phenotypic variance. Results
like these are discussed by Martin et al. (1997) where
the power to detect a QTL eﬀect was found to be
demonstrably greater (over ﬁve times) for a multi-
variate approach as compared to analysis of the mean
phenotype. In our case the inconsistency of estimates
is partly due variability in the degree of completeness
of the data. In that case the multivariate approach
enables all of the information to be incorporated in a
joint analysis. Indeed the proportion of phenotypic
variance due a QTL and its 95%CI for the mean of
the standardized scores of blood measures was 0.001
(0--0.0531) for breath measures, 0 (0--0.265) and of
both blood and breath measures, 0 (0--0.367). Sch-
mitz et al. (1998), demonstrated that multivariate
genetic analysis can lead to substantial increases in
the power to detect genetic variation by making use
of the correlations between timed measurements such
that even the present small sample sizes can be real-
istically utilized when heritabilities are greater than
about 0.5 and correlations between time points are in
the range 0.3--0.6 (Schmitz et al., 1998). The pattern
of phenotypic correlations declined over time and
corresponded to those that identify a simplex rather
than a common factor model. Moreover multivariate
modeling of QTL eﬀects is especially eﬀective in Mx
Table III. Haplotypes at the ADH1C and ADH1B Loci and their
Effects upon Alcohol Metabolism
Haplotypea 1-1 1-2 2-1
Frequency 0.528 0.431 0.041
Eﬀectb 0.45 0.51 3.22
% QTL variancec <0.01% <0.01% 0.90%
aThree haplotypes ADH1C*1--ADH1B*1 (1-1), ADH1C*1--
ADH1B*2 (1-2), and ADH1C*2--ADH1B*1 (2-1).
bEﬀect size (mg.100 ml)1) estimated in the means part of the ML
equation and equated over all measurement times.
cPercentage change of QTL variance accounted for the eﬀects of a
haplotype.
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where data points are missing for some time points
and/or phenotypes (Table I), as a univariate analysis
of every time point and phenotype would be based
upon incomplete data sets that diﬀer in their form
and extent between time points, measures of alcohol
concentration.
We used a bivariate simplex analysis to jointly
estimate the effects of a QTL on all 10 breath and 6
blood alcohol readings as a parallel time series. This
multivariate analysis has dramatically increased our
power to detect a QTL. Our analysis suggests that
64% of genetic variance in alcohol metabolism is due
to a QTL in the ADH region. The inclusion of ﬁxed
effects due to haplotypes at the polymorphic ADH1B
and ADH1C loci suggests that only a negligible
proportion of the QTL variance is attributable to
these polymorphisms.
One intriguing aspect of QTL detection concerns
the negative correlation between estimates of the
QTL contribution and those of the residual genetic
variance. The effect of this relationship, applicable to
both univariate and multivariate analysis, is to reduce
the power to detect a QTL, a factor that is dependent
upon the degree to which the residual genetic vari-
ance is solely due to stochastic events. These effects
may increase during a time series. Our estimates of
QTL effects and their statistical signiﬁcance and
conﬁdence limits from the joint simplex model in the
light of this relationship are the most optimistic that
we are likely to achieve. The most conservative
approach to QTL detection with these data is a par-
tition of the residual genetic covariance structure in
the unsimpliﬁed form of full Cholesky decomposi-
tion. This led to a model of QTL structure for the
common process of the bivariate simplex with only a
major innovation at time point 1. The chi-square
value for 1 df obtained by dropping this innovation
of variance from the model was 12.54 (p<0.001).
The simplex model provides a natural descrip-
tion of changes of covariance structure over time that
result from the physiology of alcohol absorption and
elimination, part of which is due to the in vivo enzyme
kinetics of alcohol oxidation. It is particularly useful
in the present study, as a physiological model that
satisfactorily describes the dynamics of blood alcohol
absorption detoxiﬁcation and elimination from the
body has yet to appear. Moreover, the proportion of
variation accounted for by this QTL will necessitate
its inclusion into future general models of alcohol
metabolism. Genetic variation for alcohol metabo-
lism is innovated immediately after ingestion of
alcohol. As such, the model is capable of detecting
gradual changes in effects of the same or different
genes that may be either regulatory or structural in
nature and which are realized as innovations of var-
iance in the time series.
Haplotypes for the ADH1B and ADH1C loci
showed very little evidence of anything but a minor
contribution to genetic variation in vitro metabolism
although alleles at both loci are known to be widely
different their in vitro Vmax (Bosron, et al., 1983).
Although the haplotype ADH1B*2--ADH1C*1
increases the metabolism of ethanol it is at low fre-
quency (4.1%), and its effect was at borderline sig-
niﬁcance. Allele ADH1B*2 is certainly at low
frequency in this Caucasian sample and can therefore
make, at most, a small contribution to the overall
genetic variation in these phenotypes. Given the low
frequency of the ADH1B*47His allele, the locus will
also contribute little to linkage in general. In contrast,
the QTL that we have identiﬁed by linkage to the
genomic region containing the ADH gene family
accounts for a considerable fraction of the genetic
variance for alcohol metabolism.
The joint assessment of QTL linkage and allelic
association (Fulker et al., 1999) also allows for the
detection of population admixture as a cause of allelic
association. Given the combination of small eﬀect
sizes and statistical signiﬁcance for tests of associa-
tion involving the ADH1B and ADH1C loci, any
such further partition would be uninformative A
stronger association of ADH1C locus with alcohol
consumption in the same ACTS subjects was not due
to population stratiﬁcation (Neale et al., 1999). The
ability to the contribution of a candidate locus to the
eﬀect linkage in our model is also dependent upon
genetic architecture. If the candidate locus is itself the
causal to an observed QTL eﬀect then the model
described by Fulker et al. (1999) provides a powerful
approach to the cause of an observe linkage and will
be particularly eﬀective if the common disease --
common variant view of genetic architecture is the
case (Almasy and Blangero, 2004). Nonetheless the
power to detect the eﬀect of association will be poor if
there the gene(s) of interest are tightly linked to the
test locus but not in LD with the test locus. This is
certainly a possibility since LD is not always directly
related to map distance. Although in principle it may
be more diﬃcult to detect the contribution of many
rare variants segregating within families to linkage
(should our genetic architecture conform to the rare
variant -- common ‘‘disease’’ model), newer ap-
proaches in haplotype based methods suggest a more
optimistic outlook (Lin et al., 2004). The application
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of extensive SNP genotyping to genes within ADH
gene region will permit further tests of the contribu-
tion of those polymorphisms that are at high fre-
quency to linkage.
We already know of other genes within the ADH
gene family that may have a signiﬁcant role in etha-
nol oxidation, but their contributions in the context
of our QTL are still to be investigated. For example,
the class II gene, ADH4 (p-ADH), is mainly
expressed in the human liver. It has a relatively high
Km for ethanol and at intoxicating levels of alcohol it
may account for up to 40% of ethanol oxidation in
the liver (Li et al., 1977). A polymorphic promoter
site polymorphism is also associated with ADH4 that
accounts for a twofold difference in ADH4 expression
in vitro (Edenberg et al., 1999). ADH6 (Class V) is
also expressed at its highest levels in the liver (Zhi
et al., 2000). ADH7 (Class IV; r-ADH) has a high
Vmax and high Km for ethanol and NAD
+, suggesting
it is eﬀective at high alcohol level, and is mainly
expressed in the stomach mucosa and oesophagus; it
has also been implicated as being protective against
alcoholism (Osier et al., 2004). The wider possibility
of transcriptional regulation within the ADH region
also needs to be considered with the possibility of
gene-control sequences capable of inﬂuencing an
eﬀect over long tracts of DNA (Groupp et al., 1994).
Interestingly, the retention of gene family clusters in
evolution is related to the frequency and duration of
transcription by way of a single locus control region
(Grosveld, et al., 1987; Milot et al., 1996) but an
evolutionary history of gene duplication does not
necessarily lead to any particular ordered logic in the
coding sequences of gene families or even of their
transcriptional control. Although the ADH4 locus
may be a candidate, the extent of non-coding
sequences involved in transcriptional regulation of
the ADH region has yet to be determined.
The relationship between the ADH1B and
ADH1C genes and the risk of alcohol dependence
and other drinking habits, is thought to arise from
the effects of rapid alcohol metabolism in the pres-
ence of the ADH1B*47His allele in people of East
Asian descent. There is now increasing evidence for
an involvement of the ADH region in alcohol
dependence in populations of different ethnicity. The
COGA study provides strong evidence for linkage
within the ADH region in a genome scan for
DSMIIIR diagnosis of alcohol dependence (Reich
et al., 1998) and for DSM-IV diagnosis (Williams
et al., 1999). Chromosome 4 linkage close to the ADH
region for alcohol dependence is also supported in
extended pedigrees from a South Western American
tribe in which the ADH1B*2 allele is absent (Long
et al., 1998). An indicative relationship between
alcohol dependence (DSM IIIR) and blood and
breath alcohols has been demonstrated in the ACTS
twins (Whitﬁeld et al., 2001).
Linkage disequilibrium (LD) across the ADH
gene cluster (Osier et al., 2002) makes it diﬃcult to
identify causal relationships between polymorphic al-
leles and phenotypes concerned with drinking habits.
The ADH1C (alleles ADH1C*1 and ADH1C*2) and
ADH1B (alleles ADH1B*1 and ADH1B*2) genes and
their intergenic sequences span about 15 kb (Yasun-
ami, et al., 1990), and show strong LD with aD’ value
(orD/Dmax, (Lewontin, 1964, 1988)) of.0.7 that is no
diﬀerent in alcoholics as compared to non-alcoholics
(Osier et al., 1999). There is a gross disparity in allele
frequencies for the ADH1B*2 allele between East
Asian and Caucasian ethnic groups and haplotype
analysis has also revealed that the genetic architecture
surrounding the ADH1B*2 allele differs between the
two ethnic groups (Osier et al., 2002). LD between the
ADH1B andADH1C loci in the ACTS populationwas
also estimated from genotype frequencies using the EH
and UNKNOWN algorithms (Terwilliger and Ott,
1994) so as to include information from both DZ and
MZ twins and other family members. The standard-
ized coeﬃcient of linkage disequilibriumD¢was )0.75,
close to that seen in East Asian populations; a good
agreement given the allele frequency divergence be-
tween Caucasian and East Asian peoples. Hence any
geographic or ethnic differences in the risk for alco-
holism associated with variation at the ADH1B locus
may also be due to differences in the background
genotype, and/or cultural differences.
The physiological consequences of a QTL
accounting for 64% of the genetic variation for
alcohol metabolism are likely to be manifold. The
QTL will contribute to the variance in neurophar-
macological effects in the brain because of its effect
on alcohol level following drinking, and by way of
the broad substrate speciﬁcity of the Class I and II
enzymes. Elevated alcohol levels increase neuro-
transmitter function in a variety of ways; notable
effects are increased dopamine, serotonin, endoge-
nous opioid and GABA receptor function and a
decrease in glutamate receptor function. Recent
evaluations of the kinetics of class I and II enzymes
show that the high NADH/NAD+ ratio produced
during alcohol detoxiﬁcation is also favorable for
the reduction of aldehydes to alcohols. For example,
following deamination of serotonin (5-hydroxytrypt-
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amine) by monamine oxidase, the aldehyde product
is normally oxidized by aldehyde oxidase to hy-
droxyindoleacetic acid (5HIAA). However, following
drinking, aldehyde dehydrogenase is fully saturated
by acetaldehyde from alcohol oxidation by ADH
(Helander et al., 1993), and the raised NADH/
NAD+ ratio favors the production of 5-hydroxy-
tryptophol (5HTOL) from 5HIAA by ADH
(Svensson et al., 1999). Indeed after alcohol inges-
tion the ratio of 5HTOL/5HIAA increases in a dose
related manner (Helander et al., 1994). This con-
comitant increase in serotonin metabolism may be a
factor in the development of hangover and depres-
sion related symptoms. A notable association on
chromosome 15q for single nucleotide polymor-
phisms in the GABRG3 gene with alcohol depen-
dence illustrates how the addiction may come about
in individuals with very excited nervous systems
(Dick et al., 2004). Clearly the physiological and
genetic eﬀects of the QTL for alcohol metabolism
identiﬁed here are beginning to unfold. Our task is
now to ﬁne map this region and identify the variants
responsible for this huge QTL eﬀect on ethanol
metabolism.
APPENDIX A
Following the notation of Boomsma and Mole-
naar (1987) the residual additive genetic covariance
RA, can be generally formulated for the simplex de-
sign as:
RA ¼ KyðI BÞ1wðI B0Þ1K0y: ð1Þ
Time related latent factor loadings (k1 through
kt) of the observations on the genetic factors are
estimated in the lambda matrix, Ky. In this form, the
latent genetic covariance structure (g) depends upon
both the magnitude of new innovations of genetic
variance estimated at times 1 ... t, and estimated in a
diagonal matrix w (by parameters fg1 through fgt),
and the proportion of genetic variance (bg1 through
bgt-1) transmitted to a total of (t ) 1) succeeding time
points. These latter parameters are referred to as
transmission paths and are estimated from the sub-
diagonal elements of the b matrix). The structure of
these matrices are explicitly shown in Boomsma and
Molenaar (1987).
The residual genetic variance A, at any one time
point t, can be calculated as
At ¼ k2t ðb2t At1Þ þ 1t: ð2Þ
When presented in this form, both k2t and 1
2
t provide
the same estimate of variance at time t, (Boomsma,
et al., 1989) and as such equation (2) provides two
alternative approaches to estimation. On the one
hand the variance of the innovations 1t, can be set at
unity, in which case the variance of the latent genetic
factor at time t becomes:
k2t ðb2t At1Þ þ 1: ð3Þ
Alternatively, the latent factor loadings can be
ﬁxed at unity such that the estimate of the latent
genetic factor at time t is provided by the time
dependent innovation 1t.
ðb2t At1Þ þ 1t: ð4Þ
The present bivariate simplex analysis of the
blood and breath measurements is based upon that
presented by Boomsma et al. (1989) and used both
approaches to estimation without compromising the
identiﬁcation of the model.
The application of the bivariate simplex model
to the timed series of blood and breath measurements
involves a speciﬁcation of the K, B and w matrices to
allow for the partition of eﬀects that are speciﬁc to
the blood measures as well as those that are speciﬁc
to the breath measures from the common genetic
covariance between the blood and breath measures
for the series of timed measurements, conditional
upon readings for both phenotypes being available at
the same time.
The general speciﬁcation of the matrices shown
in equation (1), then forms the basis of the estimation
procedure for the bivariate simplex model. The k
matrix in its bivariate form (size 20,30) contains six
sub-matrices in its structure:
C D O
G O F
 
;
where the diagonal matrices C and G (each size 10,10)
contain estimates of the latent genetic factors that
correspond to 10 breath and 6 blood measurements).
On the other hand diagonal matrices D and F enable
the estimation of those latent genetic factors speciﬁc
to breath or blood. A zero matrix O (size 10,10)
completes the necessary substructure of the lambda
matrix. A matrix size (30,30) with a substructure of
nine matrices each size 10,10 deﬁnes the B matrix of
transmission paths as:
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L O O
O M O
O O N
2
4
3
5;
The transmission paths are estimated as sub
diagonal elements of matrices L, M and N; those
speciﬁed in Matrix L are estimated in relation to the
common covariance for breath and blood, whilst
matrices M and N correspond to the transmission
paths that are respectively speciﬁc to breath and
speciﬁc to blood . In this part of the model, for the
speciﬁc effects only 8 (breath) and 4 (blood) trans-
mission paths are identiﬁed. The w matrix (size 30,30)
is structured to allow groups of 30 parameters or
innovation variances to be estimated on the leading
diagonal of an otherwise zero matrix. The groups
each size 10 are represented in the w matrix in the
order -- common genetic eﬀects, speciﬁc breath and
blood speciﬁc eﬀects. For identiﬁcation the simplex
speciﬁc processes speciﬁc to the either blood or
breath readings were parameterized such that neither
the innovation at the ﬁrst time point in the w matrix
nor the ﬁrst transmission path in the time series
concerned with either of the speciﬁc processes were
estimated (Fig. 3). As illustrated by equation (2) there
are two possible ways of ways in which a simplex
model can be parameterised. Here the series of
innovation variances in the w matrix the contribu-
tions of the two (blood and breath) speciﬁc genetic
time series were speciﬁed such that their corre-
sponding k elements in the submatrices D and F were
set to unity.
This led to the estimation of a time related series
of innovations of variance (f parameters) and their
corresponding transmission paths (as b parameters),
for those parts of the simplex model that measured
effects speciﬁc to blood (fls3  fls9) and (bls3--bls7) or
to breath (frs2--frs8) and (brs2--brs7) (see Fig. 3). The
contributions of the measurements from blood and
those from breath to their common genetic covari-
ance were modeled by setting the genetic factor
loadings on the joint process (estimated in submatrix
C of the w matrix) for breath to unity. In contrast the
contributions of the blood measures to the common
process are seen indirectly by estimating their genetic
factor loadings (parameters klj2--klj9) for the common
process in submatrix G matrix, whilst the corre-
sponding elements in the w matrix were set to unity
(Fig. 3). The estimates (klj2--klj9) are of the relative
contributions of breath measures to blood contribu-
tions to the common genetic covariance on those six
occasions for which both blood and breath measures
were available. The common genetic covariance was
modeled as a timed series of innovations, frj1--frj10
and transmission paths, bj1 to bj9, respectively as
described above (Fig. 3).
ELECTRONIC-DATABASE INFORMATION
The URLs for data presented herein are as fol-
lows:
 UCSC Genome Browser website (http://geno-
me.ucsc.edu/ release hg16; NCBI Build 34).
 Cartographer software (http://www.bioinfo.hel-
sinki.ﬁ/cartographer).
 NCBI website -- snp_view tables, http://
www.ncbi.nlm.nih.gov/SNP/snp_viewTable.cgi?h
=KIDDLAB.
 SNPHAP, http://www-gene.cimr.cam.ac.uk/clay-
ton/software/snphap.txt.
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